Diagnostic and Management Challenges in Pheochromocytoma and Paraganglioma: A Clinical Review.
1/5 보강
Pheochromocytoma and paraganglioma are rare neuroendocrine tumors with a prevalence of less than 0.05%.
APA
Phadte A, Karlekar M, et al. (2026). Diagnostic and Management Challenges in Pheochromocytoma and Paraganglioma: A Clinical Review.. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 58(4), 125-135. https://doi.org/10.1055/a-2792-9643
MLA
Phadte A, et al.. "Diagnostic and Management Challenges in Pheochromocytoma and Paraganglioma: A Clinical Review.." Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, vol. 58, no. 4, 2026, pp. 125-135.
PMID
41956124 ↗
Abstract 한글 요약
Pheochromocytoma and paraganglioma are rare neuroendocrine tumors with a prevalence of less than 0.05%. Being rather uncommon, they pose significant diagnostic challenges as the symptom complex is nonspecific. We present a clinical review based on the published literature and our center's experience in managing pheochromocytoma and paragangliomas over the past two decades. At the onset, summaries of three representative pheochromocytoma and paraganglioma cases are provided to highlight common diagnostic challenges. A holistic approach, combining biochemical evaluation with particular attention to pretest probability, accurate interpretation of imaging data, and differentiation from other adrenal masses, can aid in establishing the diagnosis and guiding appropriate management. Thus, the careful selection and interpretation of clinical, biochemical and imaging parameters are essential to improve diagnostic accuracy and optimize patient management.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.